Prenosis is a biotechnology company that specializes in developing advanced diagnostic solutions for personalized medicine. The company focuses on leveraging data analytics and artificial intelligence to enhance the accuracy of disease detection and treatment selection, particularly in oncology. Prenosis aims to improve patient outcomes by providing healthcare professionals with actionable insights derived from complex biological data, facilitating more informed clinical decisions. Their innovative approach seeks to transform the landscape of precision medicine by integrating real-world evidence with cutting-edge technology.